User:Elizabeth Perkins

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Line 10: Line 10:
*perkinel@ohsu.edu  
*perkinel@ohsu.edu  
-
 
-
http://portal.ohsu.edu/blogs/researchnews/2010/10/22/new-speaker-added-to-knight-seminar-series-martin-mcmahon-phd/
 
==Objectives of the Knight Cancer Institute Seminar Series==
==Objectives of the Knight Cancer Institute Seminar Series==

Revision as of 15:57, 3 January 2011

Knight Cancer Institute Seminar Series

  • Charles Keller, MD Pediatric Cancer Biology Program
  • c/o Elizabeth Perkins, Administrative Coordinator
  • Oregon Health & Science University
  • Pape'Family Pediatric Research Institute
  • Mail Code: L321
  • 3181 SW Sam Jackson Park Road
  • Portland, OR 97239
  • 503-494-9962
  • perkinel@ohsu.edu


Objectives of the Knight Cancer Institute Seminar Series

The first annual Knight Cancer Institute Seminar series, co-sponsored by the Pediatric Cancer Biology program and the Knight Cancer Institute, will have a strong presence of childhood cancer basic and translational research topics presented by leading extramural scientists.


Knight Cancer Institute Seminar Series 2010-2011 Schedule

Tuesdays 4:00pm - 5:00pm

OHSU Main Hospital 8th Floor Conference Room 8B60


  • 11/02/2010 - Martin McMahon, PhD

"Oncogenic BRAF in Tumor Initiation, Cancer Progression and Pathway-Targeted Therapy"


  • Monday 11/08/2010 - Barton A. Kamen, MD, PhD

Biomedical Research Building 3rd Floor Conference Room BRB381

"The Folate Receptor as a Model of Endoctyctyosis and as a Marker and Target in Cancer Therapy"


  • 11/30/2010 - Robert S. Krauss, PhD

"Modeling the Holoprosencephaly Spectrum in the Mouse: Regulation of Sonic Hedgehog Signaling by Co-Receptors"


  • Monday 12/02/2010 - Shaomeng Wang, PhD

Vollum Aditorium

"Targeting Protein-Protein Interactions in the Apoptosis Pathwasys for New Cancer Therapeutics"


  • 12/14/2010 - Edward E. Schmidt, PhD

"Hepatocyte Activities Revealed by Lineage and Differentiation Markers in Mice"


  • 1/18/2011 - Brian Rubin,MD, PhD

"Mechanisms of Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor"

  • 2/15/2011 - John R. Ohlfest, PhD


  • 3/08/2011 - Amy Wagers,PhD


  • 3/29/2011 - William Stratford May, MD


  • 4/12/2011 - David Bentley, PhD


  • 6/14/2011 - James Ford,MD
Personal tools